Anticoagulation therapy in pediatric patients with sinovenous thrombosis: A cohort study

Archives of Neurology

Volumn 55, Issue 12, 1998, Pages 1533-1537

  DeVeber, Gabrielle ^a,b   Chan, Anthony ^a   Monagle, Paul ^b   Marzinotto, Velma ^b   Armstrong, Derek ^b   Massicotte, Patricia ^b   Leaker, Micheal ^b   Andrew, Maureen ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ADOLESCENT; ADULT; ANTICOAGULANT THERAPY; ARTICLE; BRAIN HEMORRHAGE; BRAIN SCINTISCANNING; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; FEMALE; HUMAN; INFANT; KIDNEY DISEASE; MALE; NEWBORN; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; ORAL DRUG ADMINISTRATION; PHLEBOGRAPHY; PRIORITY JOURNAL; SINOVENOUS THROMBOSIS; SUBCUTANEOUS DRUG ADMINISTRATION; SUPERIOR SAGITTAL SINUS; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME;

EID: 0031678890     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.55.12.1533     Document Type: Article

References (23)

1. Schoenberg B, Mellinger J, Schoenberg D. Cerebrovascular disease in infants and children: a study of incidence, clinical features, and survival. Neurology. 1978; 28:763-768.
2. Broderick J, Talbot T, Prenger E, Leach A, Brott T. Stroke in children within a major metropolitan area: the surprising importance of intracerebral hemorrhage. J Child Neurol. 1993;8:250-255.
3. Roach ES, Riela AR. Pediatric Cerebrovascular Disorders. 2nd ed. Armonk, NY: Futura Publishing Co Inc; 1995.
4. Lee B, Voorhies T, Ehrlich M, Lipper E, Auld P, Vannucci R. Digital intravenous cerebral angiography in neonates. AJNR Am J Neuroradiol. 1984;5:281-286.
5. Towbin A. Central nervous system damage in the human fetus and newborn infant: mechanical and hypoxic injury incurred in the fetal-neonatal period. AJDC. 1970;119:529-542.
6. Rivkin M, Anderson M, Kaye E. Neonatal idiopathic cerebral venous thrombosis: an unrecognized cause of transient seizures or lethargy. Ann Neurol. 1992;32: 51-56
7. Shevell MI, Silver K, O'Gorman AM, Waters GV, Montes JL. Neonatal dural sinus thrombosis. Pediatr Neurol. 1989;5:161-165.
8. Ameri A, Bousser M. Cerebral venous thrombosis. Neurol Clin. 1992;10: 87-111.
9. deVeber G, Andrew M, Adams M, et al. Treatment of pediatric sinovenous thrombosis with low molecular weight heparin [abstract]. Ann Neurol. 1995;38:S32.
10. Einhaupl KM, Villringer A, Meister W, et al. Heparin treatment in sinus venous thrombosis. Lancet. 1991;338:597-600.
11. Massicotte P, Adams M, Marzinotto V, Brooker L, Andrew M. Low molecular weight heparin in pediatric patients with thrombotic disease: a dose finding study. J Pediatr. 1996;128:313-318.
12. Andrew M, Marzinotto V, Blanchette V, et al. Heparin therapy in pediatric patients: a prospective cohort study. Pediatr Res. 1994;35:78-83.
13. Hirsh J. Heparin. N Engl J Med. 1991;324:1565-1574.
14. Cruickshank M, Levine M, Hirsh J, Roberts R, Siguenza M. A standard heparin nomogram for the management of heparin therapy. Arch Intern Med. 1991;151: 333-337.
15. Andrew M, Marzinotto V, Brooker L, et al. Oral anticoagulant therapy in pediatric patients: a prospective study. Thromb Haemost. 1994;71:265-269.
16. deVeber G, Adams M, Andrew M, and the Canadian Pediatric Neurologists. Canadian Pediatric Ischemic Stroke Registry (Analysis III). Can J Neurol Sci. 1995; 22(supp 1):S21-S24.
17. Einhaupl KM, Villringer A, Haberl RL, et al. Clinical spectrum of sinus venous thrombosis. In: Einhaupl K, Kempski O, Baethmann A, eds. Cerebral Sinus Thrombosis: Experimental and Clinical Aspects. New York, NY: Plenum Press; 1990: 149-155.
18. Linker A, Hovingh P. Isolation and characterization of oligosaccharides obtained from heparin by the action of heparinase. Biochemistry. 1972;11: 563-567.
19. Hopwood J, Hook M, Linker A, Lindahl U. Anticoagulant activity of heparin: isolation of antithrombin-binding sites. FEBS Lett. 1976;69:51-54.
20. Lane D, MacGregor I, Ivan R, Cella G, Kakkar V. Molecular weight dependence of the anticoagulant properties of heparin: intravenous and subcutaneous administration of fractionated heparins to man. Thromb Res. 1979;16:651-662.
21. Johnson E, Kirkwood T, Stirling Y, et al. Four heparin preparations: anti-Xa potentiating effects of heparin after subcutaneous injection. Thromb Haemost. 1976; 35:586-591.
22. Bergqvist D, Hedner U, Sjorin E, Holmer E. Anticoagulant effects of two types of low molecular weight heparin administered subcutaneously. Thromb Res. 1983; 32:381-391.
23. Palm M, Mattsson C. Pharmacokinetics of fragmin: a comparative study in the rabbit of its high and low affinity forms for antithrombin. Thromb Res. 1987;48: 51-62.